Overview

Reduction in the Occurrence of Center-Involved Diabetic Macular Edema

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if ruboxistaurin can help slow the worsening of an eye disease called macular edema in patients with diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Chromaderm, Inc.
Treatments:
Ruboxistaurin